News

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
BDC-4182 Phase 1 dose-escalation study now open for enrollmentBDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent biological activity, ...
IAS Announces First-to-Market Partnership with Nextdoor for AI-Powered Pre-Bid Brand Safety and Suitability Optimization
Integral Ad Science (Nasdaq: IAS), a leading global media measurement and optimization platform, today announced a strategic ...